GS
CDTX

George Soros’s Cidara Therapeutics CDTX Stock Holding History

George Soros’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-275,000
Closed -$60.7M – 273
2025
Q4 		$60.7M Buy
+275,000
New +$44.4M 0.7% 49

George Soros's CDTX Position: Q1 2026 in Review

George Soros sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 275,000 shares — an estimated $60.7M sold.

George Soros first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $60.7M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • George Soros reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • George Soros sold 275,000 Cidara Therapeutics shares in Q1 2026, an estimated $60.7M.
  • George Soros first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
  • George Soros's Cidara Therapeutics position peaked at $60.7M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Soros Fund Management's 13F filing for Q1 2026, filed 15 May 2026.